These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 334337)

  • 21. Relevance of fatty acids in multiple sclerosis.
    Mertin J; Meade CJ
    Br Med Bull; 1977 Jan; 33(1):67-71. PubMed ID: 318891
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fatty diet and multiple sclerosis].
    de Andrés C; Lledó A
    Rev Neurol; 1997 Dec; 25(148):2032-5. PubMed ID: 9528051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders.
    Transler C; Eilander A; Mitchell S; van de Meer N
    J Atten Disord; 2010 Nov; 14(3):232-46. PubMed ID: 20424008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
    van Meeteren ME; Teunissen CE; Dijkstra CD; van Tol EA
    Eur J Clin Nutr; 2005 Dec; 59(12):1347-61. PubMed ID: 16118655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids.
    Field EJ; Joyce G
    Eur Neurol; 1983; 22(1):78-83. PubMed ID: 6301844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible applications of polyunsaturated fatty acids in cancer therapy.
    Spector AA; North JA; Cornelius AS; Buettner GR
    World Rev Nutr Diet; 1994; 76():81-5. PubMed ID: 7856242
    [No Abstract]   [Full Text] [Related]  

  • 27. [MaxEpa in multiple sclerosis].
    Cendrowski W
    Wiad Lek; 1985 Nov; 38(21):1522-5. PubMed ID: 3913158
    [No Abstract]   [Full Text] [Related]  

  • 28. Polyunsaturated fatty acids and epilepsy.
    Taha AY; Burnham WM; Auvin S
    Epilepsia; 2010 Aug; 51(8):1348-58. PubMed ID: 20608961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. n-3 polyunsaturated fatty acids and ischemic heart disease.
    Lancet; 1982 Sep; 2(8298):614. PubMed ID: 6125762
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A
    Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: A rational prophylactic therapy for multiple sclerosis?
    Field EJ
    Lancet; 1973 Nov; 2(7837):1080. PubMed ID: 4127326
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer mortality and polyunsaturated fatty acids.
    Singman HS; Archer M; Bergner L
    Mt Sinai J Med; 1973; 40(5):677-80. PubMed ID: 4542421
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple sclerosis: therapeutic pessimism.
    Webb HE
    BMJ; 1992 May; 304(6837):1260-1. PubMed ID: 1606425
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.
    Bates D; Cartlidge NE; French JM; Jackson MJ; Nightingale S; Shaw DA; Smith S; Woo E; Hawkins SA; Millar JH
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):18-22. PubMed ID: 2540285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary interventions for multiple sclerosis.
    Farinotti M; Simi S; Di Pietrantonj C; McDowell N; Brait L; Lupo D; Filippini G
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004192. PubMed ID: 17253500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple sclerosis and a fat-poor diet].
    Fernández O
    Neurologia; 1991; 6(7):235-7. PubMed ID: 1768440
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia.
    Akter K; Gallo DA; Martin SA; Myronyuk N; Roberts RT; Stercula K; Raffa RB
    J Clin Pharm Ther; 2012 Apr; 37(2):132-9. PubMed ID: 21501206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Multiple Sclerosis.
    Lancet; 1976 Jan; 1(7951):129-31. PubMed ID: 54642
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
    Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
    Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils.
    Leaf A; Kang JX; Xiao YF; Billman GE
    Circulation; 2003 Jun; 107(21):2646-52. PubMed ID: 12782616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.